Table 7. Financial, Human, Social Capital factors associated^* with adherence or non-adherence to antiretroviral therapy in included cross-sectional papers [n = 6, (37–42)].

	Financial Capital			Human Capital			Social Capital
Author/Year	Financial constraints/ARV payment	Household Income	Distance to clinic/Transport costs	Education	Employment Status	Food-related restrictions	Marital Status	Household size	Social support	Fear of Stigma/non-disclosure	Reasons for missing doses
Silva/2009		Higher income associated with adherence: p = 0.08, AOR: 2.33 (1.17–4.66)		8 years of schooling vs. 11 years, ns
Stout/2004			Difficulty finding transport vs. other associated with non-adherence OR: 6.3, (1.5–26.9)			Difficulty taking meds on empty stomach vs. other OR: 6.7 (1.3-35.7)					travel away from home: 17%
Uzochukwu/2009		Ns	Living 20+Km associate with adherence, p = 0.038	formal education associated with non-adherence (p = 0.0394)			being single associated with non-adherence p = 0.02				Cost and transport (30.1%), sold drugs because need money (28.2%)
Wang/2007				HIV knowledge associated with adherence OR: 5.59, (2.48–12.57), AOR: 3.20, (1.24–8.26)					Support as reminder tool associated with adherence: OR: 4.22, (1.90–9.39), AOR: 3.49, (1.36–8.96)		Community/social activities (16.3), food restrictions (11.2%), stigma (14.3%)
Weiser/2003	Cost as a barrier to treatment associated with adherence: OR: 0.15 (0.06–0.35), AOR: 0.11 (0.04–0.30)			Incomplete secondary ed compared to complete associated with adherence OR: 3.87 (1.21–12.40)			ns			Disclosure to others associated with adherence OR: 3.55 (0.91–13.92)	Financial difficulties (48%), travelling (12%), distance to clinic (5%), stigma (3%)
Williams/2007				positive, ns	positive, ns						No food, social problems

*OR: Odds Ratio, AOR: Adjusted Odds Ratio, (n₁–n₂): 95% Confidence Intervals, sig: significant, ns: not significant.